 |
|
Researcher Profile - Galila Agam |
|
|
|
| First Name: | Galila | | Last Name: | Agam | | Title: | Prof. | | Advanced Degrees: | PhD | | Affiliation: | Ben Gurion Univeristy of the Negev | | Department: | Psychiatry Research Unit & Clinical Biochemistry | | City: | Beersheva | Country/Territory: | Israel | | Phone: | 9728-6401737 | | Fax: | 9728-6401740 | | Email Address: |  |
Disclosure:
(view policy) |
Member reports no financial or other potential conflicts of interest. [Last Modified: 1 December 2005]
|
Bipolar disorder , Schizophrenia, Neurodevelopmental disorders (e.g., 22q11 deletion syndromes), Autism spectrum disorders (pervasive developmental disorders)
|
Animal models, Molecular and Cell biology, Chemistry/pharmacology, Neurodevelopment, Neuropathology, DNA microrrays, Neurotransmission, Pharmacology, Protein structure/chemistry, Signal transduction, Glutamatergic transmission
|
1968: B.Sc., Chemistry, Biochemistry, Hebrew
University, Jerusalem
1970: M.Sc., Medical Sciences/Biochemistry -
with distinction, Hebrew University and
Hebrew University Medical School,
Jerusalem. Dept. of Clinical
Biochemistry, Hadassah Medical School,
Jerusalem
1970-1980: Senior Research Assistant, in several
research labs in medical centers in
Israel
1980-1984:Instructor, Department of Biology, Ben-
Gurion University, Beer Sheva.
1984: Ph.D., Summa Cum Laude, Dept. of Life
Sciences, Ben Gurion University,
Beersheva
1989: Lecturer in Clinical Biochemistry,
Faculty of Health Sciences, Ben Gurion
University, Beersheva
1989-1997: Director, Laboratory of Biochemistry,
Soroka Medical Center, Beersheva
1993: Senior lecturer in Clinical
Biochemistry, Faculty of Health
Sciences, Ben-Gurion University,
Beersheva
1999 -: Associate Professor of Biochemistry in
Psychiatry, Ben- Gurion University,
Beersheva.
|
Agam G, Livne A, 1989: Inositol-1-phosphatase of human erythrocytes is inhibited by therapeutic Li+ concentrations. Pyschiat. Res. 27:217-224.
Levine J, Rapaport A, Lev L, Bersudsky Y, Kofman O, Belmaker RH, Shapiro J, Agam G, 1993: Inositol treatment raises CSF inositol levels. Brain Res 627:168-170.
Agam G, Shapiro Y, Bersudsky Y, Kofman O, Belmaker RH, 1994: High-dose peripheral inositol raises brain inositol levels and reverses behavioral effects of inositol depletion by lithium. Pharmacol. Biochem. Behav. 49:341-343.
Shimon H, Agam G, Belmaker RH, Hyde TM, Kleinman JE., 1997: Reduced inositol levels in frontal cortex of post-mortem brain from bipolar patients and suicides. Am. J. Psychiat. 154: 1148-1150.
Shamir A, Ebstein RP, Nemanov L, Belmaker RH, Agam G., 1998: Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy. Molec. Psychiatry 3:481-482.
Kozlovsky N, Belmaker RH, Agam G, 2000: Decreased GSK-3 immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am. J. Psychiatry. 157: 831-833.
Harwood AJ, Agam G., 2003: The search for a common mechanism of mood stabilizers. Biochemical Pharmacology, 66:179-89.
Ju S, Shaltiel G, Shamir A, Agam G, Greenberg ML., 2004: Human 1D-myo-inositol 3-phosphate synthase is functional in yeast. J Biol Chem. 279:21759-21765.
Shaltiel G, Shamir A, Shapiro J, Ding D, Dalton E, Bialer M, Harwood JA, Belmaker RH, Greenberg LM, Agam G. (2004): Valproate Decreases Inositol Biosynthesis. Biol Psychiatry 56:868-874.
Shaltiel G, Shamir A, Levy I, Bersudsky Y, Agam G. Lymphocyte G-protein receptor kinase (GRK)3 mRNA levels in bipolar disorder. Int J Neuropsychpharmacol, In press.
|
Harrison PJ, Weinberger DR., Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005 Jan;10(1):40-68;
Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, Davis NR, Ercan-Sencicek AG, Guez DH, Spertus JA, Leckman JF, Dure LS 4th, Kurlan R, Singer HS, Gilbert DL, Farhi A, Louvi A, Lifton RP, Sestan N, State MW. Sequence variants in SLITRK1 are associated with Tourette's syndrome.
Science. 2005 Oct 14;310(5746):317-20.
Lin CH, Hansen S, Wang Z, Storm DR, Tapscott SJ, Olson JM. The dosage of the neuroD2 transcription factor regulates amygdala development and emotional learning. Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14877-82. Epub 2005 Oct 3.
|
Comparison cluster analysis of differently expressed genes in postmortem brain of tens of patients vs. brain from several animal models of schizophrenia, to decipher genes associated with inheritance of the disorder vs. genes involved in its environmental factors and epi-genetics. |
Aberrant neurodevelopment and dopamine and NMDA neurotransmision |
Do mRNA or protein levels of the major genes found aberrant in patients' postmortem brain show the same deviation in the animal models of the disease.
Treatment strategies to elevate in-vivo D-serine levels.
|
|
|
|
|
|
